Miami Cancer Institute to Present Latest Cancer Research at 2023 ASCO Annual Meeting
Miami Cancer Institute, part of Baptist Health South Florida, today announced its oral and poster presentations at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, June 2-6, at McCormick Place in Chicago, Illinois.
Cracking Glioblastoma’s Deadly Code: Research Focused on Improving Diagnosis and Genomics to Revolutionize Care
Even with growing awareness of the devastating effects of glioblastoma, the most common and aggressive form of brain cancer, treatment options remain limited and patients typically survive just 15-18 months beyond diagnosis. Researchers ...
Baptist Health’s High-Tech High-Touch Approach - Live Webcast on Breast Health
Wednesday, May 31, 2023 | 5:30-6:30pm ET Join Baptist Health experts for a webinar focused on breast health; beginning with imaging through the continuum of care at Miami Cancer Institute.
Lutetium-177 (177Lu) - PSMA-617 for Metastatic Castration-Resistant Prostate Cancer: Updated National Society Guidelines
The most recent American Society of Clinical Oncology (ASCO) guidelines for the management of metastatic castration-resistant prostate cancer (mCRPC) was published in 2014.
AI: A Game-Changer in Screening Mammography
Diagnostic radiologists can scroll through upwards of 25,000 mammography images per day in search of the smallest suspicious lesion. The task is extremely taxing and image interpretation is variable.
Milestone 1000th Patient Treated Using Gamma Knife at Miami Cancer Institute
Leading the fight against brain metastases, Baptist Health Miami Cancer Institute hit a new milestone recently. The center treated its 1000th patient using Gamma Knife radiosurgery, an incisionless radiation therapy that precisely targets ...
New Class of Drugs Show Promise in Treating Recurrent Cervical Cancer
With a poor prognosis for many patients with relapsing gynecological cancers ? particularly for those who received conventional treatment only ? gynecological oncologists are on the search for novel therapies.
With a Focus on Advancing Cancer Treatments, Researchers With Baptist Health Cancer Care Focus on Trials Benefiting Patients
From a deep dive into genetic mutations to studies using novel therapies, physician-investigators at Miami Cancer Institute and Lynn Cancer Institute, part of Baptist Health Cancer Care, are conducting important leading edge research to advance cancer care.
Preventing Fractures in the Bone Mets Population
Preventing fractures in patients with bone metastasis improves mobility and quality of life ? and for some, it means prolonged survival as well, according to recent studies. While not all cancer patients have access to an orthopedic oncologic ...
Investigating Dramatic Radiation Dose Reduction For HPV-Related Head and Neck Cancers
In continuing efforts to develop effective treatments with less impact on quality of life, Miami Cancer Institute is participating in a clinical trial to reduce by more than half the radiation dosage for head and neck cancers related to ...
Cancer Rehabilitation: A Look at its Importance Throughout the Oncology Care Continuum
Join Miami Cancer Institute experts, Adrian Cristian, M.D., chief of cancer rehabilitation, and Romer Orada M.D., a physical medicine and rehabilitation physician, as they discuss the importance of cancer rehabilitation.
Combining expertise with innovation - Multimodality skin cancer treatment at Lynn Cancer Institute
The World Health Organization reports that nonmelanoma and melanoma skin cancers have been increasing over the last decade, highlighting the importance of early detection and treatment.
New Trojan Horse in Oncology: Antibody Drug Conjugate Offers Promise in Treatment of HER2-Low Breast Cancer
In a presentation at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting, Reshma Mahtani, DO, chief of breast oncology at Miami Cancer Institute, part of Baptist Health South Florida, described ADCs as the "new Trojan horses in oncology."
Innovations Using Hyperthermic lntraperitoneal Chemotherapy for Ovarian Cancer Care
The Miami Cancer Institute has one of the largest minimally invasive gynecologic surgical programs in the region.
Miami Cancer Institute Launches Global Consortium to Speed and Improve Bladder Cancer Care Worldwide
Miami Cancer Institute has spearheaded the creation of the Global Bladder Cancer Consortium (GBCC), a collaboration between the world’s top experts in bladder cancer. Among the GBCC’s priorities are creating a large and diverse patient ...
Subspecialized GI Oncologists of Benefit to Patients with GI Cancers
Gastrointestinal (GI) cancers are among the deadliest cancer diagnoses, yet not all patients with GI cancers will see a subspecialist. Considering the explosive pace at which cancer care is changing ? with the development of new medications, ...
Miami Cancer Institute First in World to Deliver Adaptive MR-Guided Radiation Therapy with the MRIdian® A3i System
At Miami Cancer Institute, part of Baptist Health South Florida, a Miami woman is now the first pancreas cancer patient in the world to be treated using an advanced platform for adaptive MR-guided radiotherapy.
Baptist Health Acquires Sophisticated New Platform for Brain Tumor Treatment
Always seeking to further the level of care available to cancer patients in the region, Baptist Health South Florida has added a sophisticated new radiosurgery platform to its arsenal of cancer-fighting technology.
Glioblastoma Patient Enrolls in Novel Clinical Trial Using Proton Therapy to Augment Survival
When Gwen Watson was diagnosed with glioblastoma (GBM), an aggressive brain cancer, she and her husband didn’t hesitate to drive four and a half hours from their home in DeLand, Florida, to Baptist Health’s Miami Cancer Institute so that ...
Miami Cancer Institute Physicians Were in the Spotlight at the 2022 Annual Meeting of the American Society of Clinical Oncology (ASCO)
Physician researchers from the Miami Cancer Institute presented the latest advances and information on new clinical trials from novel therapies to inhibit tumor proliferation and stimulate anti-cancer responses in patients with advanced solid tumors.
The Debrief with Dr. Zinner featuring guest Guenther Koehne, M.D., Ph.D.
Join Dr. Zinner., CEO and Executive Medical Director at Miami Cancer Institute and Dr. Koehne, Deputy Director and Chief of Blood & Marrow Transplant, Hematologic Oncology and Benign Hematology, on the first episode of The Debrief as they ...
Miami Cancer Institute Takes Action To Address Inequities in Cancer Care with Expanded COTA, Inc. Collaboration
Miami Cancer Institute, part of Baptist Health South Florida, will leverage COTA’s Real-World Analytics to drive standardization of care across all cancer patients
Study by Miami Cancer Institute Physician Researchers Promises to Change Way Metastatic Brain Cancer is Treated
For patients with cancer that has metastasized to the brain, the standard treatment for years has been to resect, or surgically remove, the lesion and follow that with radiation therapy (RT) to the whole brain, which prevents relapse by ...
Baptist Health’s Miami Cancer Institute named as 2022 Recipient of Warren E. Weaver/Richard P. Penna Award
The Board of Pharmacy Specialties (BPS) is pleased to announce the two Warren E. Weaver/Richard P. Penna award winners in the patient care organization and individual category. Baptist Health’s Miami Cancer Institute Pharmacy Program in ...
Beating the Odds: Pancreatic Cancer Survivor is Living Life to the Fullest
At the start of 2019, Bob Dickinson got a diagnosis no one wants - pancreatic cancer. Until very recently, pancreatic cancer cases rarely have had a happy ending, with a traditionally quoted survival rate of just 10 percent. But Mr. Dickinson ...
New Advances in the Management of Pancreatic Cancer
Originally Broadcast: November 9, 2021. Dr. Horacio Asbun, Dr. Michael Chuong, Dr. Ripal Gandhi and Dr. Govindarajan Narayanan examine recently published trial data and review their implications to unresectable locally advanced pancreatic cancer care.
New Therapies Hold Promise for Miami Cancer Institute’s Youngest Patients
According to the American Cancer Society, cancer is now the second leading cause of death, after accidents, in children under the age of 15. But, even though roughly 10,500 U.S. children will be diagnosed with cancer this year, major treatment ...
Miami Cancer Institute - Lung Cancer Conference
Originally Webcast: November 2, 2021. Dr. Mark Dylewski and the distinguished faculty from Miami Cancer Institute and Lynn Cancer Institute will discuss new advances in the management of lung cancer.
Breast Cancer Treatment Becomes Personal
Today’s breast cancer treatment has evolved into highly personalized care that begins at the molecular level and covers not only medical and surgical strategies, but the patient’s overall sense of wellness.
Miami Cancer Institute's High-Tech High-Touch Approach
Join our experts for a panel discussion on Breast Cancer & Gynecologic Cancer, originally webcast October 21, 2021. Topics included everything from breast cancer prevention, to state-of-the-art holistic treatments, and advances in gynecologic ...